Antibodies News and Research

RSS
TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

28 Jul 2022
Predicting viral antibody escape using pre-pandemic data

Predicting viral antibody escape using pre-pandemic data

28 Jul 2022
Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

28 Jul 2022
Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

28 Jul 2022
Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease

Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease

28 Jul 2022
Accurate rapid-testing device displays antibody levels in an easily readable way

Accurate rapid-testing device displays antibody levels in an easily readable way

28 Jul 2022
Weak antibody response yet robust cellular immunity identified in children after SARS-CoV-2 Omicron infection

Weak antibody response yet robust cellular immunity identified in children after SARS-CoV-2 Omicron infection

28 Jul 2022
The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

28 Jul 2022
COVID-19 Moderna vaccine induces significant antibody reactions among children

COVID-19 Moderna vaccine induces significant antibody reactions among children

28 Jul 2022
The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

28 Jul 2022
World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

28 Jul 2022
The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

28 Jul 2022
New COVID vaccine patch could better fight variants than a traditional needle, finds study

New COVID vaccine patch could better fight variants than a traditional needle, finds study

28 Jul 2022
Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

27 Jul 2022
Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

27 Jul 2022
Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

27 Jul 2022
A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

27 Jul 2022
The nose key to winning the war against COVID-19

The nose key to winning the war against COVID-19

27 Jul 2022
Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

27 Jul 2022
Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

27 Jul 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback